The French Competition Authority (“FCA”) has
just published two particularly interesting
decisions:
- The "Doctolib" decision of 6 November 2025,
in which (i) it sanctions for the first time, based on an abuse of
dominant position, a "killer acquisition"
undertaken in 2018, and (ii) it relies on
analyses drafted by the legal
department when
assessing an exclusivity
clause.
- The "Groupe Parfait" decision of 3 November
2025, which imposed a fine for failure to comply with the
commitments made in the context of an acquisition authorised in
2022, including failure to cooperate with the
trustee responsible for monitoring the commitments.
Our Antitrust, Distribution & Foreign Investments
team highlights the main takeaways of these two
decisions.